Tohashi, Japan

Shiori Ohtake

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Seikagaku Corporation. Active years: 2012.



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shiori Ohtake: Innovator in Sulfotransferase Inhibitors

Introduction

Shiori Ohtake is a prominent inventor based in Tohashi, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of sulfotransferase inhibitors. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to scientific advancement.

Latest Patents

Shiori Ohtake holds a patent for sulfotransferase inhibitors, specifically a galactosamine derivative represented by a complex formula. This invention includes various components where R, R, and R can represent different chemical groups, contributing to the efficacy of the sulfotransferase inhibitor. The patent highlights her ability to create novel compounds that may have important applications in medicine.

Career Highlights

Ohtake is currently associated with Seikagaku Corporation, where she continues to push the boundaries of research and innovation. Her work at the company has been instrumental in advancing the understanding of sulfotransferase inhibitors and their potential therapeutic uses.

Collaborations

Throughout her career, Shiori Ohtake has collaborated with notable colleagues, including Osami Habuchi and Hirofumi Nakano. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in her field.

Conclusion

Shiori Ohtake is a remarkable inventor whose work in sulfotransferase inhibitors exemplifies her commitment to scientific progress. Her contributions to the field are significant and continue to inspire future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…